When your team first integrated a third-party e-prescribing module, the decision made sense. You had an EHR to build, a market window to hit, and a DEA compliance requirement that could not slow you down. The integration model solved all three problems cleanly: fast implementation, low upfront engineering cost, and certification managed largely by someone else. You shipped. Your customers could prescribe controlled substances. The box was checked.
Then things started to shift.
Subscription invoices grew alongside your user base. Clinicians began asking why the prescribing workflow looked and behaved differently from everything else on your platform. A competitor launched a native prescribing experience that felt seamless and entirely their own. Somewhere in your product or engineering organization, someone started running the long-term numbers and asked a quieter, more strategic question: at what point does it make more sense to build this ourselves?
That question deserves a clear answer; one grounded in what both EPCS certification models actually involve, where they differ structurally, and why vendors on the integration path decide to switch to full EPCS certification.
Two Certification Models, One Structural Difference
The DEA requires that any software used to electronically prescribe controlled substances be certified under 21 CFR Part 1311. For EHR vendors, there are two distinct paths to meeting that requirement, and they compound differently over time.
Full EPCS certification applies when your EHR builds and owns the entire electronic prescribing workflow natively. Your platform handles prescription creation, prescriber identity proofing, two-factor authentication at the point of signing, pharmacy transmission, and audit trail generation, all within your own application. The DEA-approved auditor certifies your application directly against 21 CFR Part 1311 Subpart C. Your organization holds the certification. You own the compliance posture.
Integration module review applies when your EHR embeds a certified third-party e-prescribing module rather than building the prescribing workflow internally. The third-party provider holds the full EPCS certification for its own application. Your responsibility is to integrate that application correctly and ensure the integration meets DEA requirements. Compliance responsibility is shared.
The distinction is not simply build versus buy. It is ownership versus dependency. Under full certification, your platform is the certified application. Under the integration model, a third party’s platform is the certified application, and yours is a host. That structural difference has a downstream impact on cost, product control, UX continuity, and long-term compliance management, and those differences grow more visible as your user base does.
When to Choose Integration vs. Full Certification
Choosing between the integration path and full certification is ultimately a question of timing and scale. The conditions that made third-party integration attractive at launch, including speed to market, lower upfront cost, and compliance managed by someone else, do not disappear. They weigh differently as your platform grows and the long-term economics of each model come into sharper focus.
For organizations early in their growth curve, integration can remain a sound choice. It gets you to market fast, keeps upfront engineering costs low, and lets your team stay focused on building core platform functionality. The tradeoffs are manageable at that stage because the recurring fees are modest and the compliance overhead is handled externally.
The calculus shifts as your user base grows. Third-party e-prescribing platforms typically charge per provider, per practice, or per transaction. A native build carries a fixed upfront investment, with ongoing costs limited primarily to maintenance. That structure does not change as your user base grows. The more successful your product becomes, the more favorably a fixed-cost model compares to a recurring one, and most vendors find the break-even point arrives earlier than their initial analysis suggested.
Consider the effect on your users, the clinicians. Research published in JAMA Network Open has identified EHR usability as a key contributor to clinician burnout. A native prescribing workflow built to your platform’s design system eliminates the context switch entirely. Prescribers stay inside your interface. Authentication fits your existing identity infrastructure. The workflow feels like the rest of your product rather than an interruption to it. For organizations where clinician satisfaction directly affects retention or contract renewals, that coherence is worth quantifying before making the decision.
Full certification also changes your relationship with your compliance posture and product roadmap. You control the recertification timeline. You manage the audit relationship directly. You decide when to improve the prescribing experience and what those improvements look like. That control becomes more valuable as your platform matures, and customer expectations rise.
Finally, there is differentiation. When every EHR platform in your market segment uses the same third-party module, EPCS becomes a commodity feature. Vendors who build native EPCS functionality own their prescribing experience entirely and can compete on it. That is a position worth building toward, and the right time to start is usually earlier than it feels.
What the Transition Actually Involves
This is where perceived complexity tends to diverge most sharply from actual complexity. Vendors who have not been through the full EPCS certification process often assume it requires months of prepartion, extensive documentation, and a high probability of audit failure. That perception is not accurate, particularly when the process is approached with the right certification partner.
Full EPCS certification requires your application to meet the technical and functional requirements set out in 21 CFR Part 1311 Subpart C. These requirements are specific, but they are well-defined. The core areas your development team needs to address are:
- Two-factor authentication: Prescribers must authenticate using two of three approved factors (something they know, something they have, or something they are). Your application must support an approved method and enforce it at the point of prescription signing.
- Identity proofing: Verify prescriber identities through a DEA-approved provider before credentialing to ensure secure and compliant access.
- Audit trails: Your application must generate a complete, tamper-evident record of every action in the EPCS workflow (prescription creation, signing, transmission, alteration, and access control changes) retained for a minimum of two years.
- Access controls: Role-based controls must enforce separation of duties. The person who grants prescribing permissions and the person who uses them must be distinct, and every access change must be logged.
- Logical separation: Maintain workflow integrity by validating prescription fields, enforcing refill limits, and ensuring your hosted application environment is secure.
This is not a trivial build. It is a well-scoped one. The question is rarely whether it is buildable. It is whether your team has the clarity on what to build and a reliable path to getting it audited.
What the Audit Actually Tests
The EPCS certification audit is a live review of your application conducted by a DEA-approved auditor. The auditor verifies compliance with 21 CFR Part 1311 through direct interaction with the software, not through documentation review alone. Authentication flows, audit trail integrity, access control enforcement, and the completeness of your prescribing workflow from credentialing through pharmacy transmission are all tested in real time.
Drummond’s EPCS certification process requires no pre-work, no product screenshots, and no multiple form submissions before the audit begins. Most certifications are completed in two live calls with a dedicated auditor. That timeline is significantly shorter than most vendors expect going in, and the audit itself is rarely the bottleneck.
The most common source of audit delay is not a technical failure in the application, it is a gap in understanding of the requirements before development begins. Vendors who build to their own interpretation of 21 CFR Part 1311 without expert input sometimes reach the audit having missed a specific requirement or implemented something incorrectly. That is a planning problem, not an engineering problem, and it is entirely avoidable. Drummond’s approach includes ongoing gap analysis at every phase, flagging potential compliance issues before they become audit findings.
Managing the Transition Without Disrupting Existing Users
The most common reason vendors defer this decision has nothing to do with cost or certification complexity. It is the concern of disrupting clinicians who are already mid-workflow on the current integration.
That concern is legitimate. It is also more manageable than it appears.
This transition does not require a hard cutover. Vendors can continue supporting existing users on the current integration while the native module is built and certified. This parallel track keeps live workflows unaffected during development. Once certification is complete, new users onboard directly to the native experience. Existing users migrate in planned phases, on a timeline your team controls.
That sequencing matters. It means no clinician is moved before the native workflow is stable and tested. It means your customer success team has a structured rollout to communicate rather than a sudden change to explain. And it means the risks that make a hard cutover genuinely disruptive, including compressed timelines, untested workflows, and reactive support load, are designed out of the process from the start.
EHR vendors execute this class of transition regularly when updating clinical workflows or authentication systems. The migration is a project management challenge with a well-understood solution. The decision to build should not hinge on it.
How Drummond Supports the Transition
Drummond is the DEA-approved EPCS auditor that more electronic prescription software developers trust than any other.
In practice, that means no pre-work required before the formal certification process begins, a dedicated test proctor assigned to your certification from start to finish, and ongoing gap analysis at every phase so that potential compliance issues are identified and resolved before they become audit findings. The audit itself is not where time gets lost, preparation is, and Drummond’s process is built to eliminate that variable.
For vendors currently on the third-party integration path who are not yet ready to transition, Drummond also provides integration module reviews, ensuring your current integration meets DEA requirements while you evaluate the longer-term decision.
If you are an EHR vendor evaluating whether the time is right to bring your EPCS certification in-house, the most useful first step is a conversation with a Drummond EPCS auditor. There is no cost to that conversation, and no obligation. You will come away with a clear picture of what the certification process involves for your specific application, what your development team needs to build, and what a realistic timeline looks like.